![]() |
市场调查报告书
商品编码
1801264
2025 年至 2033 年乳房影像市场规模、份额、趋势及预测(按技术、最终用户和地区)Breast Imaging Market Size, Share, Trends and Forecast by Technology, End User, and Region, 2025-2033 |
2024年,全球乳房影像市场规模达48.6亿美元。展望未来, IMARC Group预测,到2033年,该市场规模将达到93亿美元,2025年至2033年的复合年增长率为7.10%。目前,北美占据乳房影像市场主导地位,2024年其乳房影像市场份额将超过37.5%。乳房影像市场的发展受到乳癌盛行率上升、影像技术进步以及政府提倡早期发现的倡议的推动。公众意识的提升、医疗基础设施的扩展以及人工智慧(AI)驱动的诊断技术进一步推动了市场成长。优惠的报销政策以及对精准、非侵入性筛检解决方案日益增长的需求也促进了行业扩张。
乳癌发生率的上升是乳房影像产业发展的主要驱动力,因此需要早期发现和先进的诊断解决方案。 2022年,全球约有230万名女性被诊断出罹患乳癌,导致约67万人死亡。然而,预测显示,到2050年,病例数将增加38%,死亡人数将增加68%。在美国,乳癌诊断率每年增长1%,50岁以下女性的诊断率每年增长1.4%。这一令人担忧的趋势促使政府加强宣传活动和倡议,提倡频繁筛检,推动了乳房X光检查、超音波检查和核磁共振成像技术的普及。三维(3D)乳房X光检查和人工智慧影像等技术进步提高了筛检准确性,减少了假阳性和不必要的活检。医疗保健基础设施的不断扩展,尤其是在新兴市场,改善了筛检中心的可近性,确保了更好的患者治疗效果,并推动了影像技术的持续创新。
美国乳房影像市场受高乳癌盛行率、先进的医疗基础设施以及政府大力推广早期筛检措施的驱动,市场份额高达88.90%。数位乳房断层合成 (DBT) 和人工智慧诊断等先进影像技术的广泛应用,提高了筛检的准确性和效率。优惠的报销政策以及美国癌症协会等组织所进行的宣传活动,进一步鼓励人们定期进行乳房X光检查。此外,主要产业参与者持续的研发投入也促进了技术进步,提高了成像精度。主要市场参与者的加入,加上医疗创新投资的不断增加,进一步增强了乳房影像市场的成长。保险覆盖范围的扩大和个性化诊断需求的不断增长,进一步推动了乳房影像解决方案在全美范围内的普及。
乳癌发生率上升
乳房影像市场的主要趋势之一是乳癌病例数量的增加,这是推动乳房影像产业成长的主要因素之一。早期发现可提高生存率,从而改善治疗效果,因此对先进影像的需求激增。根据世界卫生组织的数据,乳癌是女性最常见的癌症,因此必须及时准确检测乳癌。根据世界癌症研究基金会的数据,预计2030年将新增约210万例乳癌病例,这进一步证明了对有效筛检和影像解决方案的需求。乳癌病例的增加推动了先进影像技术的引入,同时也促使医疗系统和医疗服务提供者采用更好的安全诊断方案。早期发现对于改善治疗效果至关重要,而乳房影像服务的需求也在成长,以适应这些不断增长的需求变数和乳房影像市场。
成像技术的进步
乳房影像技术的持续进步显着提升了乳房疾病的检测和管理水平,预计将成为市场成长的关键驱动力。值得注意的是,数位乳房X光检查、3D断层合成、增强乳房X光检查以及人工智慧驱动的成像解决方案的进步,都有助于提高诊断的精准度和效率,从而推动其应用。此类创新使医疗保健提供者能够更早、更准确地诊断乳癌,从而改善患者的预后。近期一个很好的例子是通用电气医疗集团 (GE HealthCare) 于2023年11月推出的MyBreastAI套件;它结合了三款由iCAD引入的人工智慧驱动的应用程式:用于2D乳房X光检查的SecondLook、用于3D乳房X光检查的ProFound AI以及PowerLook密度评估。该套件利用人工智慧技术简化乳房成像流程,以便更快地进行诊断,从而改善此类成像的可及性。这些技术都满足了市场对更优质、更精准的癌症检测设备日益增长的需求,并将进一步促进乳房影像市场的需求。
政府和医疗机构提高乳癌认知度的倡议
日益增多的宣传活动和政府倡议使得越来越多的乳房影像服务得以应用,因为早期检测对于生存至关重要。世界各国政府和组织正在推出乳癌筛检项目,扩大影像服务的可近性,特别是针对服务匮乏的人。这些倡议反过来又将诊断技术扩展到了先前尚未普及的领域,进一步刺激了市场成长。例如,每两年,由政府资助的澳洲国家筛检计画「澳洲乳房筛检」(BreastScreen Australia)都会为50-74岁的女性提供免费的乳房X光检查,以鼓励筛检和早期检测。此外,澳洲癌症协会于2020年9月发布的《早期乳癌管理指南—建议与实务要点》强调了早期诊断的重要性,从而推动了先进乳房影像技术的发展。这些倡议,加上公众意识的不断提升,在增加对高品质影像解决方案的需求以及全球乳房影像市场扩张方面发挥重要作用。
The global breast imaging market size was valued at USD 4.86 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 9.30 Billion by 2033, exhibiting a CAGR of 7.10% from 2025-2033. North America currently dominates the market, holding a breast imaging market share of over 37.5% in 2024. The breast imaging market is driven by rising breast cancer prevalence, technological advancements in imaging modalities, and government initiatives promoting early detection. Increased awareness, expanding healthcare infrastructure, and artificial intelligence (AI)-driven diagnostics further boost market growth. Favorable reimbursement policies and growing demand for accurate, non-invasive screening solutions also contribute to industry expansion.
The rising incidence of breast cancer is a major driver in the breast imaging industry, necessitating early detection and advanced diagnostic solutions. In 2022, approximately 2.3 million women globally were diagnosed with breast cancer, resulting in about 670,000 deaths. However, the projections indicate a 38% increase in cases and a 68% rise in deaths by 2050. In the U.S., diagnoses have been growing by 1% annually, with a 1.4% increase per year among women under 50. This alarming trend has intensified awareness campaigns and government initiatives promoting frequent screenings, driving the adoption of mammography, ultrasound, and MRI technologies. Technological advancements like three-dimensional (3D) mammography and AI-powered imaging enhance accuracy, reducing false positives and unnecessary biopsies. Expanding healthcare infrastructure, particularly in emerging markets, improves access to screening centers, ensuring better patient outcomes and continuous innovation in imaging technology.
The U.S. breast imaging market is driven by high breast cancer prevalence, advanced healthcare infrastructure, and strong government initiatives promoting early detection with 88.90% market share. Widespread adoption of advanced imaging technologies, such as digital breast tomosynthesis (DBT) and AI-driven diagnostics, enhances accuracy and efficiency in screenings. Favorable reimbursement policies and increased awareness campaigns by organizations like the American Cancer Society further encourage regular mammograms. Additionally, ongoing research and development (R&D) efforts by key industry players contribute to technological advancements, improving imaging precision. The presence of major market players, coupled with rising investments in healthcare innovations, strengthening the breast imaging market growth. Expanding insurance coverage and growing demand for personalized diagnostics further support the increasing adoption of breast imaging solutions across the country.
Increasing Incidence of Breast Cancer
On of the primary breast imaging market trends is the increasing number of breast cancer cases is one of the leading factors driving the growth of the breast imaging sector. Early detection improves survival and hence the treatment, thus surging demand for advanced imaging. It is the most commonly diagnosed cancer among women, as per WHO, necessitating accurate and timely detection of breast cancer. According to the World Cancer Research Fund, it is anticipated that there will be around 2.1 million new breast cancer cases in 2030, strengthening the argument for effective screening and imaging solutions. The rise of breast cancer cases drives the introduction of advanced imaging technologies while pushing the health system and providers to adopt better options in secure diagnosis. The measure of early detection is instrumental in improving treatment outcomes, and the demand for breast imaging services rises to accommodate these increased demand variables and the market for breast imaging.
Technological Advancements in Imaging Techniques
Continuous advancement in breast imaging technology significantly influences enhancement in detection and management of breast illnesses and conditions and is projected as a key driver for market growth. Notably, advancement in digital mammography, 3D tomosynthesis, contrast-enhanced mammography, and AI-driven imaging solutions, all contribute to increased diagnostic precision and efficiency, which in turn drives adoption. Innovations such as these allow healthcare providers to make earlier and more precise diagnoses of breast cancer, leading to improved outcomes for patients. An excellent recent example is the MyBreastAI suite launched by GE HealthCare in November 2023; it combines three iCAD-introduced AI-driven applications: SecondLook for 2D mammography, ProFound AI for 3D mammography, and PowerLook Density Assessment. This suite uses AI technology to streamline breast imaging for quicker diagnosis, thereby improving access to this kind of imaging. These technologies are all answers to the growing demand for better and more accurate devices for cancer detection that will further facilitate the breast imaging market demand.
Government and Healthcare Initiatives for Breast Cancer Awareness
The increasing awareness campaigns and government initiatives are allowing more and more breast imaging services to be utilized as early detection is very crucial to survival. Governments and organizations around the world are introducing breast cancer screening programs, expanding access to imaging services, especially for underserved populations. These, in turn, have expanded diagnostics into areas where they had previously not been available, further spurring market growth. For instance, every two years, the government-sponsored national screening program of Australia, BreastScreen Australia, offers women ages 50-74 free mammograms to encourage screening and early detection. Moreover, Cancer Australia's September 2020 publication, "Guidance for the Management of Early Breast Cancer-Recommendations and Practice Points," emphasized the significance of early diagnosis, stimulating the development of advanced breast imaging technologies. These instances, accompanied by a growing awareness among the public, are playing an important role in increasing the demand for high-quality imaging solutions and expanding the breast imaging market globally.
According to the breast imaging market forecast, Ionizing breast imaging holds the majority share of 63.7% due to its widespread use in early breast cancer detection and diagnosis. Techniques such as mammography, digital breast tomosynthesis (DBT), and contrast-enhanced mammography provide high-resolution images, enabling accurate identification of abnormalities. The effectiveness of these methods in detecting microcalcifications and early-stage tumors makes them the preferred choice among healthcare providers. Additionally, government screening programs, rising breast cancer awareness, and increased adoption of advanced imaging technologies contribute to its dominance. The integration of artificial intelligence in mammography for improved diagnostic accuracy and workflow efficiency further strengthens market growth. Despite concerns over radiation exposure, continuous technological advancements in low-dose imaging ensure its continued preference in breast cancer diagnostics.
Based on the breast imaging market outlook, Hospitals hold the largest market share of 42.0% due to their comprehensive veterinary care services, advanced diagnostic capabilities, and specialized treatment options. These facilities offer a wide range of medical interventions, including surgeries, critical care, and disease management, making them the preferred choice for pet owners and livestock farmers. The presence of skilled veterinary professionals, access to high-end medical equipment, and increasing investments in hospital infrastructure contribute to their dominance. Additionally, rising pet adoption rates and growing awareness of preventive healthcare are driving demand for hospital-based veterinary services. Government initiatives and corporate investments in multi-specialty veterinary hospitals further strengthen their market position, ensuring better accessibility and higher standards of animal healthcare across urban and rural areas.
North America holds the leading market position with a 37.5% breast imaging market share, fueled by a robust healthcare infrastructure, widespread adoption of advanced medical technologies, and rising healthcare expenditures. The region benefits from strong government initiatives supporting disease screening, early diagnosis, and treatment advancements. A growing prevalence of chronic diseases, coupled with a rising aging population, fuels demand for cutting-edge medical imaging and diagnostic solutions. Additionally, robust research and development activities, along with a high concentration of key industry players, contribute to market growth. Favorable reimbursement policies and widespread health insurance coverage further boost accessibility to medical imaging services. Increasing awareness programs and strong regulatory frameworks ensure continued investment in healthcare innovations, reinforcing North America's market dominance.
United States Breast Imaging Market Analysis
Growing demand for next-generation breast imaging technologies in the US stems from the large number of regulatory clearances, growing rates of breast cancer diagnoses, and revised screening guidelines. In January 2021, Seno Medical Instruments gained Premarket Approval from CDRH for its new diagnostic modality in imaging, which is centered on the malignant vs. benign differentiation of breast lesions. This approval supports the rising adoption of advanced imaging solutions for accurate diagnosis. Meanwhile, the guidance from the CDC, released in September 2020, and recommendations from major institutes for cancer research on yearly screenings for women, aged 40 to 49, run a further push for the demand for imaging services. The Breastcancer.org states that around 281,550 fresh cases of invasive in women were diagnosed in the U.S. of breast cancer, enhancing the demand for early detection technologies. A combination of these factors results in the expanding breast imaging market in the United States.
Europe Breast Imaging Market Analysis
The increase in aging populace in Europe is a key driving force behind the growth of the breast imaging market, as aging is a significant risk factor for breast cancer. As per a report by the European Union, by February 2025, over 21.3% of the total EU population which is approximately 448.8 million-was aged 65 years and older in 2023. The changing demographics are foreseen to result in an increased incidence of breast cancer, hence driving the demand for advanced breast imaging technologies. With focus across Europe on early detection and preventive care, investments in screening programs and diagnostic imaging solutions are continuing to rise. Governments and healthcare companies are expanding the access to mammography, ultrasound, and MRI-based breast imaging services to respond to the rising need for timely and accurate diagnoses. Thus, the rising population and growing healthcare initiatives were expected to drive the European breast imaging market in the coming years.
Asia Pacific Breast Imaging Market Analysis
The increasing number of breast cancer incidences recorded in the Asia Pacific region, coupled with improving healthcare infrastructure, act as the main growth driver for the breast imaging market. According to a report published by Breast Cancer Network Australia in September 2024, approximately 20,973 women and 221 men will be diagnosed with breast cancer in Australia alone. This rising number of cases highlights the requirement for advanced breast imaging technologies to enable early identification and efficient treatment.
Governments and healthcare organizations in the region are investing in newer screening technologies, including digital mammography, ultrasound, and MRI services. Supportive initiatives on breast cancer awareness and early screening programs provide good access to breast imaging services, especially in developing countries. With ongoing improvements in healthcare infrastructure and adoption of state-of-the-art imaging technologies, the demand for breast imaging solutions in the Asia Pacific region is projected to grow steadily in the future.
Latin America Breast Imaging Market Analysis
Breast cancer is the most prevalent form of cancer among women in Latin America and Caribbean countries, compelling a growing interest in the development of advanced breast imaging technologies. According to the American Society of Clinical Oncology (ASCO), more than 200,000 new cases of breast cancer were diagnosed in the region in 2020. As such increased incidence demands for greater awareness and provides an impelling reason for the development of breast imaging market.
Breast cancer screening programs are actively implemented across the Latin American region by the government and health agencies to promote the early detection of this disease. Investment in advanced imaging modalities, including digital mammography, ultrasound, and MRI, has opened the door to equitable access to high-quality diagnostics. Also, awareness campaigns and partnerships with global health institutions are slowly closing the programs that detect breast cancer among poor communities. As these health systems develop and screening access improves, demand for breast imaging solutions is expected to rise steadily across Latin America.
Middle East and Africa Breast Imaging Market Analysis
The trials of rising breast cancer incidence in the Middle East and North Africa (MENA) are among the major forces influencing breast imaging growth. In 2019, there were 835,576 breast cancer cases among females and 10,938 among males, as per the Institute for Health Metrics and Evaluation (IHME). Incidence and burden of breast cancer here drive home the point quite well about the need for deployment of advanced imaging technology and methods for early detection and improved outcomes.
Governments and healthcare institutions in the Middle East and Africa are investing in expanding access to breast cancer screening programs. Countries such as the UAE, Saudi Arabia, and South Africa are implementing nationwide initiatives promoting regular mammograms and early diagnosis. The increasing adoption of digital mammography, 3D tomosynthesis, and AI-powered imaging solutions increases accuracy and accessibility to diagnosis. Furthermore, rising healthcare awareness, improved medical infrastructure, and partnerships with international health organizations will calm beyond the horizon in the regional market.
The breast imaging market is highly competitive, driven by continuous technological advancements and innovation in diagnostic imaging solutions. Market players focus on research and development to enhance imaging accuracy, reduce false positives, and integrate artificial intelligence for improved diagnostics. The industry sees strong competition in product differentiation, with companies offering advanced modalities such as digital breast tomosynthesis, automated breast ultrasound, and molecular breast imaging. Strategic collaborations with healthcare providers and research institutions play a crucial role in market positioning. Regulatory approvals and compliance with stringent safety standards influence market dynamics. Additionally, increasing mergers and acquisitions help companies expand their portfolios and global reach, intensifying competition while driving the overall evolution of breast imaging technologies.